Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-04-07EMA Authorised: Adtralza (tralokinumab) — LEO Pharma A/S
The EMA authorised Adtralza (tralokinumab) by LEO Pharma A/S for atopic dermatitis in the European Union. Decision date: 26 March 2026.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients [Phase 1]
Pfizer's first-in-human Phase 1 study is evaluating the tolerability of PF-07832837 in healthy adults and in patients with atopic dermatitis…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Studies of Skin Microbes in Healthy People and in People With Skin Conditions
A National Human Genome Research Institute-sponsored clinical trial is recruiting to study skin microbes in healthy people and in individual…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema [Phase 3]
Pfizer is conducting a long-term Phase 3 study of Abrocitinib for moderate-to-severe atopic dermatitis in children aged 2 years and older; t…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis [Phase 3]
Phase 3 clinical trial update for SHR-1819 Injection in adolescents with moderate-to-severe atopic dermatitis. The study is currently recrui…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Effects of Treatments on Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial sponsored by NIAMS is evaluating treatments for atopic dermatitis (eczema) and related dermatitis conditions, curre…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis [Phase 3]
A Phase 3 study evaluating adverse events and changes in disease activity comparing oral upadacitinib with subcutaneous dupilumab in childre…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema [Phase 3]
Pfizer is conducting a Phase 3 study of abrocitinib in children aged 6 to less than 12 years with moderate-to-severe eczema, and the trial i…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Registry for Systemic Eczema Treatments
A Johns Hopkins University clinical trial registry entry for Atopic Dermatitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety, pharmacokinetics, and preliminary efficacy of UCB9741 in healthy participants and in indiv…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: A Clinical Study to Evaluate SM17 in Healthy Participants [Phase 1]
Phase 1 trial evaluating SM17 in healthy participants has completed. The study lists Atopic Dermatitis, Asthma, and Inflammatory Bowel Disea…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Natural History of Severe Allergic Inflammation and Reactions
This update describes the completed observational study on the natural history of severe allergic inflammation across several rare immunoder…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Clinical Study to Evaluate SM17 for Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial evaluating SM17 for atopic dermatitis is currently recruiting; no results are reported yet.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2a trial evaluating the efficacy, safety, and tolerability of GIA632 in adults with moderate-to-severe atopic dermatitis; recruitment …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants [Phase 1]
A Phase 1 clinical trial evaluating SKB575 (HBM7575) injections in healthy participants and participants with atopic dermatitis is currently…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Xerosis and Use of Topical Moisturizer [NA]
A clinical trial update about xerosis due to atopic dermatitis evaluating the use of a topical moisturizer; the study is currently active bu…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis [Phase 2]
Phase 2b safety and efficacy study of CGB-500 topical ointment containing 0.5% and 1% tofacitinib for atopic dermatitis has completed.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Study Evaluating TRIV-509 in Atopic Dermatitis [Phase 2]
This clinical trial update reports a Phase 2 study evaluating TRIV-509 for atopic dermatitis, which is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: A Study to Assess Efficacy and Safety of CGB-500, 1% Tofacitinib Versus an Active Comparator for Atopic Dermatitis [Phase 2]
A Phase 2 trial evaluated the efficacy and safety of CGB-500, a 1% topical tofacitinib, versus an active comparator for atopic dermatitis. T…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis [Phase 1]
Phase 1 clinical trial update for ENV-294 in healthy adults and adults with moderate-to-severe atopic dermatitis; the study has completed.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Dietary Intervention on Atopy [NA]
A dietary intervention trial for individuals with atopy, including atopic dermatitis and allergic rhinitis, is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Natural History and Genetics of Food Allergy and Related Conditions
Ongoing NIAID study aims to characterize the natural history and genetics of food allergy and related conditions, including Loeys-Dietz synd…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
This is a non-interventional disease registry enrolling adolescents and adults with atopic dermatitis who initiate or switch systemic treatm…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SIM0718 in Adult and Adolescent Patients With Moderate to Severe Atopic Dermatitis [Phase 3]
A Phase 3 clinical trial evaluating SIM0718 for efficacy and safety in adults and adolescents with moderate to severe atopic dermatitis has …
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2b study evaluating rezpegaldesleukin (Rezpeg) for adults with moderate-to-severe atopic dermatitis is ongoing and currently not recru…